Безопасен ли kojic isopalmitate при беременности?
No harmonised reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive hazard flagged for kojic isopalmitate; no convincing animal or human reproductive/teratogenic data in peer-reviewed literature indicating reproductive hazard. The compound is more lipophilic than kojic acid so topical absorption is low but measurable; therefore exposure during pregnancy is low but not negligible. Sources consulted: ECHA (no harmonised CLP for this substance), PubChem, CosIng, CIR (general kozic/kojic-derivative safety reviews), PubMed (no clear repro/teratogenic findings).
Related ingredients
Frequently asked questions
- Безопасен ли kojic isopalmitate при беременности?
- No harmonised reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive hazard flagged for kojic isopalmitate; no convincing animal or human reproductive/teratogenic data in peer-reviewed literature indicating reproductive hazard. The compound is more lipophilic than kojic acid so topical absorption is low but measurable; therefore exposure during pregnancy is low but not negligible. Sources consulted: ECHA (no harmonised CLP for this substance), PubChem, CosIng, CIR (general kozic/kojic-derivative safety reviews), PubMed (no clear repro/teratogenic findings).
- Безопасен ли kojic isopalmitate при грудном вскармливании?
- No evidence of reproductive or lactation-specific hazard or harmonised classification. Low but measurable dermal absorption expected with topical use; transfer into milk is not documented. Same rationale as pregnancy: no hazard data identified, exposure potential is low.
- Безопасен ли kojic isopalmitate для кожи малыша?
- No infant-specific reproductive/toxicity data found. Dermal exposure for infants should be considered higher due to immature barrier and higher surface-area-to-weight; adult exposure judged low but measurable (e=1), so per guidance baby exposure is increased by +1 to e=2. No evidence supports increased hazard or a specific reproductive mechanism in infants.
- Как VeriMom оценивает kojic isopalmitate?
- VeriMom оценивает kojic isopalmitate в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы kojic isopalmitate при беременности?
- См. наш список безопасных альтернатив kojic isopalmitate с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.